Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-17-012607
Filing Date
2017-11-27
Accepted
2017-11-27 16:39:15
Documents
2
Period of Report
2017-11-16

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT f3111617amouyal_wize.html 3  
1 OWNERSHIP DOCUMENT f3111617amouyal_wize.xml 3 1803
2 POWER OF ATTORNEY f3111617amouyalex24_wize.htm EX-24 7830
  Complete submission text file 0001213900-17-012607.txt   11116
Mailing Address 5B HANAGAR STREET HOD HASHARON L3 4527708
Business Address 5B HANAGAR STREET HOD HASHARON L3 4527708 972 472 260 0536
Wize Pharma, Inc. (Issuer) CIK: 0001218683 (see all company filings)

EIN.: 880445167 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 5 MAZEH ST. TEL AVIV L3 65213
Business Address
Franck Amouyal (Reporting) CIK: 0001723469 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-52545 | Film No.: 171223298